Novel Synthesis of Bicycles with Fused
Pyrrole, Indole, Oxazole, and Imidazole
Rings
Alan R. Katritzky,* Sanjay K. Singh, and Sergey Bobrov
Center for Heterocyclic Compounds, University of Florida,
Department of Chemistry, Gainesville, Florida 32611-7200
Received August 20, 2004
FIGURE 1. Pyrrolo[1,2-c]oxazol-1-ones 1, oxazolo[3,4-a]indol-
1-ones 2, pyrrolo[1,2-c]imidazoles 3, imidazo[1,5-a]indoles 4,
and imidazo[1,5-a]indoles 5.
Abstract: Reactions of benzotriazol-1-yl(1H-pyrrol-2-yl)meth-
anone 10 and benzotriazol-1-yl(1H-indol-2-yl)methanone 11
with diverse ketones, isocyanates, and isothiocyanates in the
presence of base afforded pyrrolo[1,2-c]oxazol-1-ones 1, ox-
azolo[3,4-a]indol-1-ones 2, pyrrolo[1,2-c]imidazoles 3, and
imidazo[1,5-a]indoles 4 by a simple one-step procedure.
SCHEME 1
Pyrrolo[1,2-c]imidazole and imidazo[1,5-a]indole deriva-
tives exhibit a wide spectrum of biological activity. Thus,
pyrrolo[1,2-c]imidazole-1,3-diones 3 (X ) O) are of inter-
est due to their antidiabetic1 and aldose reductase inhibi-
tory activity.2 Applications of imidazo[1,5-a]indoles 5 (X
) O, S) derivatives include their use as central nervous
depressants, analgesics,3 and 5-NT3 receptor antago-
nists.4 Various 3-thioxo-2,3-dihydroimidazo[1,5-a]indol-
1-ones 4 (X ) S) have been evaluated as light-dependent
TNF-R antagonists5 and antifungals.6 Several examples
of oxazolo[3,4-a]indol-1-ones 2 (R ) R1 ) Ar) from indolyl-
2-carboxylic acid chloride and substituted 4,4′-bisalky-
laminobenzophenones have all been reported by Fukui.7
No pyrrolo[1,2-c]oxazol-1-ones 1 have been recorded.
5,6,7-Trisubstituted pyrrolo[1,2-c]imidazole-1,3-diones
3 (X ) O) have previously been synthesized by cyclocon-
densation from the corresponding 2-pyrrolocarbonylami-
noacetates with carbonyl diimidazole.1,2 Papadopoulos8,9
employed isocyanates and alkali salts of pyrroles to first
generate the pyrrole-1-carboxamides 6, which were then
condensed with phosgene or thiophosgene in the presence
of a base to give pyrrolo[1,2-c]imidazoles 3 (X ) O; R )
Ph and X ) S; R ) H, Ph) (Scheme 1 (i)). He also treated
pyrrole-2-carboxamides 7 (R ) Ph, CO2Et) with phenyl
isocyanate in the presence of a base to give 3 (X ) O; R
) Ph) (Scheme 1 (ii)).10,11
SCHEME 2
condensed the appropriate indole-2-carboxylic acid 8 (R
) alk, allyl; R1 ) alk, alkoxy; R2 ) H; Z ) OH) or its
methyl ester (Z ) OMe) with isocyanate or isothiocyanate
in the presence of triethylamine at high temperatures
to give 4 (R1 ) alk, alkoxy; R2 ) H; X ) O, S) in moderate
to low yields (Scheme 2 (iii)). Unstable acid chloride 8 (R
) H; R1 ) 5-Cl; R2 ) 2-fluorophenyl; Z ) Cl) generated
in situ was condensed with urethane to give imidazo[1,5-
a]indole 4 (R ) Ph; R1 ) 5-Cl; R2 ) 2-fluorophenyl; X )
O) (Scheme 2 (iii)).12 Papadopoulos also reacted indole-
2-carbonyl compounds 8 (R1 ) R2 ) H; Z ) NHPh, OEt)
with phenyl isocyanate to form 4 (R1 ) R2 ) H; X ) O)
(Scheme 2 (iii)).14 Compound 4 (R1 ) R2 ) H; R ) H; X )
S) has also been prepared in moderate yield by reaction
of indole-2-carbonyl isothiocyanate 9 with sodium meth-
anethiolate (Scheme 2 (iv)).6,13
The synthetic strategies previously employed for com-
pounds of type 4 are depicted in Scheme 2. Carter5
The valuable and diverse biological properties of com-
pounds incorporating the pyrrolo[1,2-c]imidazole or imi-
dazo[1,5-a]indole ring system encouraged the develop-
ment of efficient methods for their preparation. The pyr-
rolo[1,2-c]oxazoles 1 (Figure 1) represent rare types of
fused heterocycles with a bridgehead nitrogen atom. This
work reports a novel synthetic method for the ring closure
to fused heterocyclic bicycles such as pyrrolo[1,2-c]oxazol-
1-ones 1, oxazolo[3,4-a]indol-1-ones 2, pyrrolo[1,2-c]imi-
(1) Ogawa, K.; Yamawaki, I.; Matsushita, Y. Jpn. Kokai. Patent JP
04297478; Chem. Abstr. 1992, 118, 234056.
(2) Yamawaki, I.; Matsushita, Y.; Asaka, N.; Ohmori, K.; Nomura,
N.; Ogawa, K. Eur. J. Med. Chem. 1993, 28, 481.
(3) Wright, W. B. US Patent 3,565, 902; Chem. Abstr. 1971, 75,
36033.
(4) Varasi, M.; Heidempergher, F.; Caccia, C.; Salvati, P. PCT Int.
Appl. WO 9532209; Chem Abstr. 1995, 124, 232456.
(5) Voss, M. E.; Carter, P. H.; Tebben, A. J.; Scherle, P. A.; Brown,
G. D.; Thompson, L. A.; Xu, M.; Lo, Y. C.; Yang, G.; Liu, R.-Q.;
Strzemienski, P.; Everlof, J. G.; Trzaskos, J. M.; Decicco, C. P. Bioorg.
Med. Chem. Lett. 2003, 13, 533.
(6) Kutschy, P.; Suchy, M.; Dzurilla, M.; Takasugi, M.; Kovacik, V.
Collect. Czech. Chem. Commun. 2000, 65, 1163.
(7) Fukui, T.; Kondo, Y. Jpn. Kokai. Patent JP 04223467, 1992.
(8) Papadopoulos, E. P. J. Org. Chem. 1966, 31, 3060.
(9) Papadopoulos, E. P. J. Org. Chem. 1973, 38, 667.
(10) Papadopoulos, E. P.; Habiby, H. S. J. Org. Chem. 1966, 31, 327.
(11) Papadopoulos, E. P. J. Org. Chem. 1972, 37, 351.
(12) Ishizumi, K.; Inaba, S.; Yamamoto, H.J. Org. Chem. 1973, 38,
2617.
(13) Kutschy, P.; Dzurilla, M.; Takasugi, M.; Sabova, A. Collect.
Czech. Chem. Commun. 1999, 64, 348.
(14) Papadopoulos, E. P.; Bedrosian, S. B. J. Org. Chem. 1968, 33,
4551.
10.1021/jo0485334 CCC: $27.50 © 2004 American Chemical Society
Published on Web 11/12/2004
J. Org. Chem. 2004, 69, 9313-9315
9313